Premature ejaculation (PE) is one of the most common male sexual complaints and can significantly affect quality of life and relationships.^1,2 While behavioral strategies can help some men, especially as an adjunct, our treatment approach emphasizes evidence-based medical treatments ranging from on-demand topical therapies to oral medications, tailored to your specific situation, symptoms, and whether erectile dysfunction (ED) coexists.^2,3

Topical anesthetics: Often our preferred first-line option for men seeking on-demand, non-systemic treatment.^2,3 In the United States, lidocaine/prilocaine products used for PE are typically off-label.^3,4 Lidocaine/prilocaine creams or metered-dose sprays, applied to the glans before intercourse, reduce sensitivity and can meaningfully increase time-to-ejaculation.^2,4,5 Exact timing depends on formulation: some sprays are used at least 5 minutes before intercourse, while creams may require 20 to 30 minutes.^4,5 Low systemic absorption means systemic side effects are generally limited when used as directed.^2,5 Main considerations include reduced sensation, possible transfer to a partner causing vaginal numbness, minimized by wiping off excess product before intercourse and, depending on the product, using a condom, and caution in couples actively trying to conceive because lidocaine/prilocaine products may reduce sperm motility and could lower the chance of pregnancy.^2,4,5

Dapoxetine: A short-acting SSRI specifically developed for on-demand PE treatment, taken 1 to 3 hours before sexual activity.^2,6 Clinical trials show about a 2- to 3-fold improvement in ejaculatory latency.^2,7 While approved in Europe and other countries outside the United States, dapoxetine is not FDA-approved in the United States.^2,3,6 We mention it for completeness.

Daily SSRIs and clomipramine: Off-label in the United States, but core treatment tools.^2-4 Delayed ejaculation is a well-known serotonergic effect that becomes therapeutic here.^2,3 Paroxetine tends to produce the largest delay among SSRIs; on-demand low-dose clomipramine, taken a few hours before intercourse, is an effective alternative for men who prefer not to take daily medication.^2,3 With daily SSRIs, effects typically become noticeable within days, with fuller benefit often taking 1 to 2 weeks.² Side effects are the standard serotonergic profile: nausea, fatigue, reduced libido, and in some cases delayed or absent orgasm, which require upfront discussion and medication review.^2,3

PDE5 inhibitors: When PE coexists with erectile dysfunction, optimizing erections is often the appropriate first step.^2,3 Even in men without clear ED, PDE5 inhibitors may improve confidence, perceived control, and sexual satisfaction, although evidence that they consistently increase ejaculation latency on their own is less robust.^2,3 Combination SSRI plus PDE5 inhibitor has also been shown to outperform SSRI alone in some studies, particularly when ED is also part of the picture.^2,3

We tailor our approach based on whether PE is lifelong or acquired, whether symptoms are consistent or situational, whether ED is a contributing factor, and whether you prefer on-demand or daily medication, providing practical, judgment-free treatment for a condition that can significantly impact quality of life and relationships.^1-3

References

1. El-Hamd MA, Saleh R, Majzoub A. Premature ejaculation: an update on definition and pathophysiology. Asian J Androl. 2019;21(5):425-432. https://pubmed.ncbi.nlm.nih.gov/30860082/
2. European Association of Urology. EAU Guidelines on Sexual and Reproductive Health. 2026 ed. Presented at the EAU Annual Congress; 2026; London, United Kingdom. https://uroweb.org/guidelines/sexual-and-reproductive-health/chapter/citation-information
3. Shindel AW, Althof SE, Carrier S, et al. Disorders of ejaculation: an AUA/SMSNA guideline. J Urol. 2022;207(3):504-512. doi:10.1097/JU.0000000000002392. https://pubmed.ncbi.nlm.nih.gov/34961344/
4. Montague DK, Jarow J, Broderick GA, et al. AUA guideline on the pharmacologic management of premature ejaculation. J Urol. 2004;172(1):290-294. doi:10.1097/01.JU.0000132159.61156.EA. https://pubmed.ncbi.nlm.nih.gov/15201797/
5. European Medicines Agency. Fortacin, INN-lidocaine, prilocaine: product information. Accessed April 16, 2026. https://www.ema.europa.eu/en/documents/product-information/fortacin-epar-product-information_en.pdf
6. European Medicines Agency. Priligy (dapoxetine): package leaflet and referral information. Accessed April 16, 2026. https://www.ema.europa.eu/en/documents/referral/priligy-article-29-referral-annex-iii_en.pdf
7. McMahon CG, Althof SE, Kaufman JM, et al. Efficacy and safety of dapoxetine for the treatment of premature ejaculation: integrated analysis of results from five phase 3 trials. J Sex Med. 2011;8(2):524-539. doi:10.1111/j.1743-6109.2010.02097.x. https://pubmed.ncbi.nlm.nih.gov/21059176/